Clinical Trial Update: Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach [Phase 4]

View source ↗

Summary

This phase 4 clinical trial compares low and high doses of dexmedetomidine during transsphenoidal pituitary tumor surgery; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Adenoma

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Mahidol University | Conditions: Pituitary Tumor | Phase 4 | Status: UNKNOWN